Atlas Trials

TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)

Clinical trial NCT02676089 · COMPLETED

Trial details

NCT number
NCT02676089
Sponsor
Chiesi Farmaceutici S.p.A.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Asthma
Start date
2016-04-06
Primary completion
2018-05-28
Enrollment
1437

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.